Uncommon cutaneous manifestations of lupus erythematosus

Lupus

Volumn 6, Issue 2, 1997, Pages 122-131

  Mascaro, J M ^a   Herrero, C ^a   Hausmann, G ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Anetoderma; Bullous lupus; Chilblain lupus; Hypertrophic lupus erythematosus; Lupus panniculitis; Maculopapular mucinosis

Indexed keywords

ANETODERMA; ARTICLE; BULLOUS SKIN DISEASE; COLD INJURY; HUMAN; MUCINOSIS; PANNICULITIS; PAPULE; PRIORITY JOURNAL; RASH; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031058688     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600207     Document Type: Article

References (84)

1. Bechnet PE. Hypertrophic lupus erythematosus. Arch Dermatol Syphiliol 1940; 42: 211-213.
2. Rothfield NF. Lupus erythematosus. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freeberg MI, Austen KF (eds). Dermatology in General Medicine. MCGraw-Hill, Inc: New York, 1993, pp 2138.
3. Sherman RN, Lee CW, Flynn KJ. Cutaneous squamous cell carcinoma in black patients with chronic discoid lupus erythematosus. Int J Dermatol 1993; 32: 677-679.
4. Millard LG, Barker DJ. Development of squamous cell carcinoma in chronic discoid lupus erythematosus. Clin Exp Dermatol 3; 1978: 161-166.
5. Caruso WR, Stewart ML, Nanda VK, Quismorio FP Jr. Squamous cell carcinoma of the skin in black patients with discoid lupus erythematosus. J Rheumatol 1987; 14: 156-159.
6. Perniciaro C, Randle HW, Perry HO. Hypertrophic lupus erythematosus resembling squamous cell carcinoma. Dermatol Surg 1995; 21: 255-257.
7. Vinciullo C. Hypertrophic lupus: differenciation from squamous cell carcinoma. Australas J Dermatol 1986; 27: 76-82.
8. Uitto I, Santa-Cruz DJ, Eisen AZ, Leone P. Verrucous lesions in patients with discoid lupus erythematosus: clinical, histopathological and immunofluorescence studies. Br J Dermatol 1978; 98: 507-520.
9. Seiger E, Roland S, Goldman S. Cutaneous lupus treated with topical tretinoin: a case report. Cutis 1991; 47: 351-355.
10. Green S, Piette W. Treatment of hypertrophic lupus erythematosus with isotretmoin. J Am Acad Dermatol 1987; 17: 364-368.
11. Kaposi M. Pathologie und Therapie der Hautkrankheiten. 2nd End. Urban and Schwarzenberg; Wien, 1883, S642.
12. Irgang S. Lupus erythematosus profundus: report of an example with clinical resemblance to Darier-Roussy sarcoid. Arch Dermatol Syph 1940; 42: 97-108.
13. Arnold HL. Lupus erythematosus profundus: Commentary and report of four more cases. Arch Dermatol 1956; 73: 15-33.
14. Tuffanelly DL. Lupus erythematosus panniculitis (profundus). Clinical and immunologic studies. Arch Dermatol 1971; 103: 231-242.
15. Winkelmann RK. Panniculitis and systemic lupus erythematosus. JAMA 1970; 211: 472-475.
16. Winkelmann RK, Szasz Peters M, Sanchez N. Lupus panniculitis (American Society of Dermatopathology. Abstracts). Arch Dermatol 1980; 116: 1391.
17. Sanchez NP, Szasz Peters M, Winkelmann RK. The histopathology of lupus erythematosus panniculitis. J Am Acad Dermatol 1981; 122: 576-582.
18. Ackermann AB, Jakobson M, Vitale P. Clues to diagnosis in dermatopathology. Chicago; ASCP, 1991, pp 398.
19. Izumi A, Takiguchi P. Lupus erythematosus panniculitis. Arch Dermatol 1983; 119: 61-64.
20. Süus R et al. Lupus erythematodes profundus Kaposi-Irgang. Hautarzt 1994; 45: 38-41.
21. Caproni M, Palleschi GM, Papi C, Fabri P. Discoid lupus erythematosus lesions develop on lupus erythematosus profundus nodules. Int J Dermatol 1995; 34: 357-359.
22. Magee KL et al. Lupus erythematosus profundus with periorbital swelling and proptosis. J Am Acad Dermatol 1991; 24: 288-290.
23. Holland NW, McKnight K, Challa VR, Agudelo C. Lupus panniculitis (profundus) involving the breast: report of 2 cases and review of the literature. J Rheumatol 1995; 22: 344-346.
24. Lever WP, Schaumburg-Lever G. Connective tissue diseases. In: Histopathology of the skin, 7th edn JB Lippencott: Philadelphia, 1990, pp 505.
25. Harris RB, Duncan SC, Ecker RI. Lymphoid follicles in subcutaneous inflammatory disease. Arch Dermatol 1979; 115: 442-443.
26. Yamada Y, Dekio S, Jidoi S, Ozasa S. Lupus erythematosus profundus - report of a case treated with dapsone. J Dermatol 1989; 16: 379-382.
27. Borrous NP, Walport MJ, Hammond AH. Lupus erythematosus profundus with patial C4 deficiency responding to thalidomide. Br J Dermatol 1991; 115: 62-67.
28. Fox JN, Klapman MH, Rowe L. Lupus profundus in children: Treatment with hydroxichloroquine. J Am Acad Dermatol 1987; 16: 839-844.
29. Ruiz Rodriguez R, Longaker M, Berger TG. Anetodermia and human immunodeficiency virus infection. Arch Dermatol 1992; 128: 661-662.
30. Ryll-Nardzewski C, Kudejko T, Kudejko J. Remarques sur le lupus érythémateux profond de Kaposi-Irgang et sur l'anetodermie erythematoide. Ann Dermatol Syphil 1960; 87: 627-636.
31. Disdier et al. Primary anetoderma associated with the antiphospholipid syndrome. J Am Acad Dermatol 1994; 30: 133-134.
32. Venecie PY, Winkelmann RK, Moore BA. Anetoderma. Clinical findings, associations and long term follow-up evaluation. Arch Dermatol 120; 1984: 1032-1039.
33. Bergman R, Friedman-Birnbaum R. An immunofluorescence study of primary anetoderma. Clin Exp Derm 1990; 15: 124-130.
34. Kodak et al. Immunologic abnormalities associated with primary anetoderma. Arch Dermatol 1992; 128: 799-803.
35. Schnitzler L, Abimelech PH. Anétodermia lupique pseudotumorale. Chorée infantile. Evolution sur 28 ans. Ann Dermatol Venereol 1988; 115: 679-685.
36. Disdier et al. Primary anetoderma associated with the antiphospholipid syndrome. J Am Acad Dermatol 1994; 30: 133-134.
37. Hodak et al. Primary anetoderma associated with a wide spectrum of autoimmune abnormalities. J Am Acad Dermatol 1991; 25: 415-418.
38. Stephansson et al. Lupus anticoagulant and the skin. Acta Dermato Venereol 1991; 71: 416-422.
39. Thibierge G. Le lupus érythémateux à forme d'atrophodermie en plaques. Ann Derm Syphil 1905; 6: 913-926.
40. Randle HW, Müller S. Generalized elastolysis associated with systemic lupus erythematosus. J Am Acad Dermatol 1983; 8: 869-873.
41. Bechet PE, Elizabeth NJ. Lupus erythematosus telangiectoides. Arch Dermatol 1948; 58: 128-133.
42. Hutchinson J. Harveian lectures on lupus. The varieties of common lupus. Br Med J 1988; 1: 58-63.
43. Su WPD, Perniciaro CH, Rogers III RS, White JW. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis 1994; 54: 395-399.
44. Millard LG, Rowell NR. Chilblain lupus erythematosus (Hutchinson) A clinial and laboratory study of 17 patients. Br J Dermatol 1978; 98: 497-506.
45. Shrank AB. Chilblain lupus erythematosus. Proc Soc R Med 1964; 57: 515.
46. Marks R. Chilblain lupus erythematosus as a manifestation of lymphoma. Proc Soc R Med 1967; 60: 494-496.
47. Breathnach SM, Wells GC. Chilblain lupus erythematosus with response to chemical sympathectomy. Br J Dermatol 1979; 101 (Suppl. 17): 49-51.
48. Rowell NR. Chilblain lupus erythematosus responding to etretinate. Br J Dermatol 1987; 117 (Suppl. 32): 100-102.
49. Allegue F, Alonso ML, Rocamora A, Ledo A. Chilblain lupus erythematosus and antiphospholipid antibody syndrome. J Am Acad Dermatol 1988: 908-910.
50. Uter W, Proksh E, Schauder S. Chilblain-Lupus erythematodes. Hautarzt 1988; 39: 602-605.
51. Doutre et al. Chilblain lupus erythematosus: Report of 15 cases. Dermatology 1992; 184: 26-28.
52. Stainforth J, Goodfield MJD, Taylor PV. Pregnancy-induced chilblain lupus erythematosus. Clin Exp Dermatol 1993; 18: 449-451.
53. Doutre MS et al. Chilblain lupus erythematosus: report of 15 cases. Clin Lab Invest 1992; 184: 26-28.
54. Yell JA et al. Bullous systemic lupus erythematosus: revised criteria for diagnosis. Br J Dermatol 1995; 132: 921-928.
55. Gammon WR, Briggaman RA. Bullous eruption of systemic lupus erythematosus. In: Wojnarowska F, Briggaman RA (eds). Management of Blistering Diseases. Champan and Hall: London, 1990, pp 263-275.
56. Gammon WR, Briggaman RA. Bullous SLE. A phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol 1993; 100: 28S-34S.
57. Sontheimer RD. Clinical manifestations of cutaneous lupus erythematosus. In: Wallace DJ, Hahn BH (eds). Dubois's Lupus Erythematosus. Lea & Febiger Philadelphia, 1993, pp 298.
58. Sontheimer RD, Gilliam JN. Subacute cutaneous lupus erythematosus. Current Concepts in Skin Disorders 1983; 4: 11-17.
59. Bielsa I, Herrero C, Font J, Mascaro JM. Lupus erythematosus and toxic epidermal necrolysis. J Am Acad Dermatol 1987; 16: 1265-1267.
60. Wechsler HL, Stavrides A. Systemic lupus erythematosus with anti-Ro antibodies: Clinical, histologic and immunologic findings/ Report of three cases. J Am Acad Dermatol 1982; 6: 73-83.
61. Herrero C et al. Subacute cutaneous lupus erythematosus: Clinicopathologic findings in thirteen cases. J Am Acad Dermatol 1988; 19: 1057-1062.
62. Lee LA, Norris DA. Mechanisms of cutaneous tissue damage in lupus erythematosus. In: Norris DA (ed). Immune mechanisms in Cutaneous Diseases Marcel Dekker inc: New York, 1989, pp 359-386.
63. Fleming HG et al. Bullous systemic lupus erythematosus. Int J Dermatol 1989; 28: 321-326.
64. Hall RP, Lawley TJ, Smith HR, Katz SI. Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy. Ann Intern Med 1982; 97: 165-170.
65. Gold SC. An unusual papular eruption associated with lupus erythematosus. Br J Dermatol 1954; 66: 429-433.
66. Rongioletti F, Rebora A. The new cutaneous mucinoses: a review with an up-to-date classification of cutaneous mucinoses. J Am Acad Dermatol 1991; 24: 265-270.
67. Storck R, Schirren CG, Meurer M, Kind P. Die papulöse Muzinose. Eine seltene kutane manifestation des lupus erythematodes. hautarzt 1994; 45: 642-646.
68. Lowe L, Rapini RP, Golitz Le, Johnson TM. Papulonodular dermal mucinosis in lupus erythematosus. J Am Acad Dermatol 1992; 27: 312-315.
69. Eskreis BD, Bronson DM. Cutaneous mucinosis in a child with systemic lupus erythematosus. Pediatric Dermatol 1992; 9: 259-263.
70. Kobayashi T et al. Plaquelike cutaneous lupus mucinosis. Arch Dermatol 1993; 129: 383-384.
71. Jakson BA, Norum RA, Lowe L, Fivenson DP. Papulonodular dermal mucinosis in systemic lupus erythematosus. J Rheumatol 1994; 21: 940-941.
72. Pandya AG et al. Papulonodular mucinosis associated with systemic lupus erythematosus: possible mechanisms of increased glycosaminoglycan accumulation. J Am Acad Dermatol 1995; 199-205.
73. Moulin G et al. Mucinose papuleuse photodépendante et lupus érythémateux. Ann Dermatol Venereol 1982; 107: 1193-1198.
74. Weidner F, Djawari D. Mucinosis papulosa bei lupus eythematodes integumentalis. Hautartz 1982; 33: 286-288.
75. Nishimoto M, Takaiwa T, Kodama H, Nohara N. Cutaneous mucinosis associated with SLE: a case provoked by PUVA. J Dermatol 1989; 16: 374-378.
76. Galofré J et al. Mucinosis papulonodular y lupus entematoso sistemico de comienzo tardio asociado a tiroiditis de Hashimoto y síndrome de Sjögren. Rev Clin Esp 1989; 184: 446-447.
77. Tsuchida T, Fureu M, Kashiwado T, Ishibashi Y. Bullous systemic lupus erythematosus with cutaneous mucinosis and leukocytoclastic vasculitis. J Am Acad Dermatol 1994; 31: 387-390.
78. Egawa H, Abe-Matsuura Y, Tada J, Arata J. Nodular cutaneous lupus mucinosis associated with atrophie blanche-like lesions in a patient with systemic lupus erythematosus. J Dermatol 1994; 21: 674-679.
79. Aquilina CH, Sayag J. Lupus érythémateux et papules. Quatre observations. Ann Dermatol Venereol 1991; 118: 593-605.
80. Kennedy C, Gold SC, Moss R. Systemic lupus erythematosus with an unusual papular eruption. Br J Dermatol 1979; 101 (Suppl. 17): 51-53.
81. Lin RY, Landsman L, Krey PR, Lambert WC. Multiple dermatofibromas and systemic lupus erythematosus. Cutis 1986; 37: 45-49.
82. Choi EH, Hann SK, Chung KY, Park YK. Papulonodullar cutaneous mucinosis associated with systemic lupus erythematosus. Int J Dermatol 1992; 31: 649-652.
83. Vázquez GM, Ramírez J, Cortés MP, Gamarra AI. un caso de lupus asociado a mucinosis papulonodular. Rev Invest Clin 1994; 46: 63-66.
84. Fowler JF, Callen JP. Cutaneous mucinosis associated with lupus erythematosus. J Rheumatol 1984; 11: 380-383.